Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06182319
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2023-11-30
Brief Title:
Optimizing Treatment of Adhesive Small Bowel Obstruction
Sponsor:
University of California Los Angeles
Organization:
University of California Los Angeles
Study Overview
Official Title:
The Use of Nasogastric Tubes And Water-Soluble Contrast In The Management Of Small Bowel Obstruction A Feasibility Study
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Small bowel obstruction SBO is one of the most common causes of serious gastrointestinal disease in the US Adhesion-related SBO aSBO is usually treated by the placement of a nasogastric tube NGT to decompress the stomach administration of intravenous IV fluids and observation by a surgical team
The purpose of this feasibility study is to determine the potential for implementation of treatment protocols for aSBO and determine the feasibility of randomizing patients with aSBO to receive or not receive NGTs or water-soluble contrast WSC The investigators will also determine the ability to measure HRQOL as a main outcome for the treatment of aSBO The studies outlined in this research program intend to address gaps in knowledge about how to determine who benefits from NGT placement who can be managed without them how to objectively determine when a bowel obstruction has resolved how to reintroduce feeding to patients with aSBO what criteria should be used for hospital discharge and what role cathartics such as WSC contrast have in the management of aSBO
This feasibility study will enroll a limited number of patients n40 who will be followed for up to 30 days
The purpose of this feasibility study is to determine the potential for implementation of treatment protocols for aSBO and determine the feasibility of randomizing patients with aSBO to receive or not receive NGTs or water-soluble contrast WSC The investigators will also determine the ability to measure HRQOL as a main outcome for the treatment of aSBO The studies outlined in this research program intend to address gaps in knowledge about how to determine who benefits from NGT placement who can be managed without them how to objectively determine when a bowel obstruction has resolved how to reintroduce feeding to patients with aSBO what criteria should be used for hospital discharge and what role cathartics such as WSC contrast have in the management of aSBO
This feasibility study will enroll a limited number of patients n40 who will be followed for up to 30 days
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None